Journal
CARDIOVASCULAR TOXICOLOGY
Volume 15, Issue 4, Pages 366-376Publisher
HUMANA PRESS INC
DOI: 10.1007/s12012-014-9305-8
Keywords
Connexin 43; Doxorubicin; Mitochondria; Hsp90
Categories
Funding
- Programma Operativo Regionale (POR) Campania Model Organism (MODO) FSE
- Programma Operativo Regionale (POR) FSE Research in Experimental Medicine (CREME)
Ask authors/readers for more resources
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity and consequent dysfunction. It has been proposed that the etiology of this is related to mitochondrial dysfunction. Connexin 43 (Cx43), the principal protein building block of cardiac gap junctions and hemichannels, plays an important role in cardioprotection. Recent reports confirmed the presence of Cx43 in the mitochondria as well. In this study, the role of mitochondrial Cx43 was evaluated 3 or 6 h after Doxorubicin administration to the rat heart cell line H9c2. Pharmacological inhibition of Hsp90 demonstrated that the mitochondrial Cx43 conferred cardioprotection by reducing cytosolic and mitochondrial reactive oxygen species production, mitochondrial calcium overload and mitochondrial membrane depolarization and cytochrome c release. In conclusion, our study demonstrates that Cx43 plays an important role in the protection of cardiac cells from Doxorubicin-induced toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available